Saturday, 10 October 2026
Saturday, 10 October 2026
- In brief
- 1A Danish ethics panel and Guinea-Bissau approve a US-funded trial that delays the hepatitis B vaccine for half of 14,000 newborns
- 2Psychiatrists warn over a livestreamed execution
- 3Fever after a vaccine traced to gut bacteria
- 4England to inspect private ADHD clinics
- 5Census changes would bend US health figures
- 6A numbing fluid eases IUD fitting
- 7Muscle and liver cells remember training
- 8Walking faster matched walking further
- 9A low-glutamate diet tried on Gulf War veterans
- 10More US counties lose private Medicare drug plans
- 11A second UK health body drops Teva
- 12Teen podcasts on memory and dyslexia win
- 13Most English adults with high blood pressure do not know
- 14A blood clue to how the immune system ages
- 15Eye-damage lawsuits over weight-loss drugs
- 16US measles cases pass 4,000
- 17A Catholic memorial to people lost to suicide
- 18Gambling-addiction charity chief quits over Kalshi money
- 19Australian PMOS group asks for subsidised weight-loss drugs
10 Oct · Mind & body · In brief
Mind & body · Saturday, 10 October 2026
Mind & body, in brief
19 stories · 37 sources
Swipe up for the day in brief ↑Scroll down for the day in brief ↓
What is moving · 1 of 3
Officials overruling expert warnings
A Danish university committee approved the Guinea-Bissau trial after its expert members argued against it.
What is moving · 2 of 3
Claims ahead of the trials
Robert F Kennedy Jr says an old Danish study showed hidden vaccine injuries, but a follow-up by the same team found none.
What is moving · 3 of 3
Care getting harder to reach
In England, 810,000 people wait for an ADHD or autism assessment as NHS staff leave for private clinics.
19 stories
- 1A Danish ethics panel and Guinea-Bissau approve a US-funded trial that delays the hepatitis B vaccine for half of 14,000 newborns
- 2Psychiatrists warn over a livestreamed execution
- 3Fever after a vaccine traced to gut bacteria
- 4England to inspect private ADHD clinics
- 5Census changes would bend US health figures
8 sources
Mind & body, in brief
- 1Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau
- 9Execution live stream could cause PTSD in viewers, say psychiatrists
- 10Pentagon says execution of Fort Hood shooter will be livestreamed
- 19NHS faces exodus of ADHD and autism services staff to private clinics
- 20Opinion: Proposed U.S. census changes could be catastrophic for public health
- 22One doctor's fight to make IUD placement better
- 25Cutting 1 compound from processed foods could reduce brain fog, anxiety, and chronic pain, scientists say
- 26Medicare Advantage Plan Availability Varies Widely by County for 2027
A Danish ethics panel and Guinea-Bissau approve a US-funded trial that delays the hepatitis B vaccine for half of 14,000 newborns
Swipe up for the story ↑Scroll down for the story ↓
An ethics committee at the University of Southern Denmark voted this week to let a US-funded vaccine trial go ahead in Guinea-Bissau, a small country in West Africa.
One of them had presented the study to the committee.
Who is involved
Christine Stabell Benn and Peter Aaby
Danish researchers who run the Bandim Health Project in Guinea-Bissau; they lead the trial [5]
Who is involved
Robert F Kennedy Jr
the US health secretary, a longtime vaccine opponent; he praised the researchers and backs the trial [1]
Why it matters
Watch whether the Africa CDC, the African Union's health agency, tries to stop the trial again; an official there said on Thursday that talks with the US were going on.
What's really going on
The US health department under Robert F Kennedy Jr, whose vaccine advisers dropped the US birth-dose advice in December, is paying Danish researchers to test that dose on babies in Guinea-Bissau.
What's really going on
The trial can run there because Guinea-Bissau does not give the dose yet, and a Danish university committee approved it over its own expert members.
Why it works on people
The line that no baby gets fewer vaccines than national policy gives sounds like no harm, because it measures the babies against the country's current gap instead of against the birth dose the WHO says every newborn should get.
Who gains
Robert F Kennedy Jr
The trial gives his case against a universal birth dose a study he can point to, and he has praised the researchers in public.
Who gains
The Bandim Health Project researchers
They receive a $1.6 million CDC grant, matched by two private foundations, for a trial they proposed themselves.
Who pays
Babies in the trial's delayed group
They go six weeks without hepatitis B protection in a country where infection in infancy usually lasts for life.
Nobody knows yet
How many babies in the delayed group would catch hepatitis B because of the trial.
The plan described in February was not built to count hepatitis B infections, and the new protocol has not been made public.
Nobody knows yet
What the updated trial plan actually says.
Details were shared with the Guardian but not published, and the CDC, the researchers and Guinea-Bissau's health minister did not answer its questions.
Nobody knows yet
How common hepatitis B is among adults in Guinea-Bissau.
The WHO estimates more than 12% for 2022, while the Guardian reports about 18% and Scientific American 18.7%; we cannot say which count is newer.
Nobody knows yet
How long the second group waits, and how many babies take part.
The Guardian and the BBC say six weeks and 14,000 babies; STAT described a first dose at two months and about 14,500 babies, from an earlier plan.
The short version
That's the story in short.
The whole story has 13 more parts.
or swipe up for the next storyor scroll on for the next story ↓
The whole story, in 13 parts ↓
Part 1 of 13 · Who else is involved
Quinhin Nantote
Guinea-Bissau's health minister; he said in January the trial was suspended, and his government has now approved it [1][7]
Part 1 of 13 · Who else is involved
The WHO
the UN's health agency, which advises every country; it called the trial unethical in February [2][4]
Part 2 of 13 · How it unfolded
Dec 2025
The US CDC awards $1.6 million to the Danish team for the trial
Feb 2026
The WHO calls the trial unethical
Part 3 of 13
Guinea-Bissau's officials have approved it too, although its health minister, Quinhin Nantote, said in January that the trial was suspended.
Part 4 of 13
The trial plans to enrol 14,000 newborns.
Part 4 of 13
Half get the hepatitis B vaccine at birth, and half get no hepatitis B vaccine for their first six weeks.
Part 5 of 13
Hepatitis B is a virus that attacks the liver.
Part 5 of 13
About 9 in 10 newborns infected at birth carry it for life, at high risk of liver scarring and liver cancer.
Part 6 of 13
Guinea-Bissau does not yet give a birth dose; babies get their first dose at six weeks, and a birth dose for every baby is now planned for 2028.
Part 7 of 13
The researchers, Christine Stabell Benn and Peter Aaby, say no baby gets fewer vaccines than national policy gives, and they want to test for health effects nobody has measured.
Part 8 of 13
The WHO, the UN's health agency, called the plan unethical in February.
Part 8 of 13
It says leaving one group untreated is only acceptable when no proven treatment exists.
Part 9 of 13
Stig Borsen Hansen, who presented the study to the Danish committee, resigned in protest on Friday, and three other members have also resigned.
Part 10 of 13
The plan now tests mothers first and keeps babies of infected mothers out of the trial.
Part 10 of 13
In earlier research, half of children who caught hepatitis B got it after birth, from people around them.
Part 11 of 13
The test for mothers misses about 1 in 20 infections, the Guardian reports, and Paul Offit, an infection doctor in Philadelphia, says the virus can spread on shared toothbrushes and washcloths.
Part 12 of 13
The US CDC, the country's public health agency, has reportedly set aside $1.6 million, matched by two private foundations.
Part 12 of 13
It awarded the grant without a competition.
Part 13 of 13
Experts say a five-year trial can count early harms but not the benefit, because liver damage from an infection in infancy shows up decades later.
8 sources
A Danish ethics panel and Guinea-Bissau approve a US-funded trial that delays the hepatitis B vaccine for half of 14,000 newborns
- 1Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau
- 2Proposed CDC-funded hep B trial in Africa unethical, WHO chief says
- 3Guinea-Bissau: Planned US-funded baby vaccine trial blasted by WHO
- 4Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau
- 5CDC grant goes to Danish researchers with ties to Tracy Beth Hoeg
- 6A Controversial U.S. Study of Hepatitis B Vaccines Will Continue in Africa, HHS says
- 7Is this controversial U.S.-funded vaccine trial on or off?
- 8Guinea-Bissau: Plans for controversial U.S.-funded vaccine study need review
The full story
A Danish ethics panel and Guinea-Bissau approve a US-funded trial that delays the hepatitis B vaccine for half of 14,000 newborns
An ethics committee at the University of Southern Denmark voted this week to let a US-funded vaccine trial go ahead in Guinea-Bissau, a small country in West Africa.
Guinea-Bissau's officials have approved it too, although its health minister, Quinhin Nantote, said in January that the trial was suspended.
The trial plans to enrol 14,000 newborns. Half get the hepatitis B vaccine at birth, and half get no hepatitis B vaccine for their first six weeks.
Hepatitis B is a virus that attacks the liver.
Guinea-Bissau does not yet give a birth dose; babies get their first dose at six weeks, and a birth dose for every baby is now planned for 2028.
The researchers, Christine Stabell Benn and Peter Aaby, say no baby gets fewer vaccines than national policy gives, and they want to test for health effects nobody has measured.
The WHO, the UN's health agency, called the plan unethical in February. It says leaving one group untreated is only acceptable when no proven treatment exists.
Stig Borsen Hansen, who presented the study to the Danish committee, resigned in protest on Friday, and three other members have also resigned.
The plan now tests mothers first and keeps babies of infected mothers out of the trial. In earlier research, half of children who caught hepatitis B got it after birth, from people around them.
The test for mothers misses about 1 in 20 infections, the Guardian reports, and Paul Offit, an infection doctor in Philadelphia, says the virus can spread on shared toothbrushes and washcloths.
The US CDC, the country's public health agency, has reportedly set aside $1.6 million, matched by two private foundations. It awarded the grant without a competition.
Experts say a five-year trial can count early harms but not the benefit, because liver damage from an infection in infancy shows up decades later.
Why it matters. Watch whether the Africa CDC, the African Union's health agency, tries to stop the trial again; an official there said on Thursday that talks with the US were going on.
Psychiatrists warn over a livestreamed execution
Swipe up for the story ↑Scroll down for the story ↓
The US defence department confirmed on Thursday that it will livestream the firing-squad execution of Nidal Hasan at Fort Hood on 3 December.
Hasan, a former army psychiatrist, killed 13 people and wounded 32 at the base in 2009.
It would be the first US military execution since 1961, and the first public execution in the US since the 1930s.
- 1Last big public execution in the US1,936
- 2Last US military execution1,961
- 3Planned livestreamed execution at Fort Hood2,026
Mental health experts warned that watching could cause post-traumatic stress, most of all in people with existing mental health problems.
The UN human rights office said broadcasting the killing would breach the ban on torture.
Why it matters
Research after other attacks points the same way.
Why it matters
After 9/11, how much coverage people watched was linked to stress symptoms for three years, and among 744 Israeli teenagers surveyed after the 7 October attack, heavy news-watchers had more symptoms.
Why it matters
Distress also drives people to watch more, which brings more distress.
Who pays
Viewers with existing mental health problems
Neil Greenberg says they are most at risk of distress if they watch the execution.
Nobody knows yet
Whether the Fort Hood execution will be livestreamed at all.
Hasan can still ask a federal court to review his case, which could delay it for years, and the US defence department has given few details of the stream.
Nobody knows yet
How many viewers a livestreamed execution would harm.
Psychologist Simon Duff says there is little research on watching executions; the evidence comes from journalists and from news coverage of attacks.
9 sources
Psychiatrists warn over a livestreamed execution
- 9Execution live stream could cause PTSD in viewers, say psychiatrists
- 10Pentagon says execution of Fort Hood shooter will be livestreamed
- 11'Medieval' and 'disturbing': US plan to livestream execution
- 12Post-traumatic stress among adolescents following the October 7th attack in Israel: implications for mental health policy
- 13The Impact of Adverse News About the Gaza War on the Health of Iranian Elderly People: A Qualitative Study
- 14Longitudinal PTSD trajectories before and after the October 7, 2023, terror attacks: A nationwide study of Israeli adults
- 15Pete Hegseth's plan to livestream execution puts US in dubious company
- 16The U.S. last held a public execution in the 1930s. The Pentagon wants to change that
- 17Army Sets Date for First Military Execution by Firing Squad Since 1945
The full story
Psychiatrists warn over a livestreamed execution
The US defence department confirmed on Thursday that it will livestream the firing-squad execution of Nidal Hasan at Fort Hood on 3 December.
- 1Last big public execution in the US1,936
- 2Last US military execution1,961
- 3Planned livestreamed execution at Fort Hood2,026
Why it matters. Research after other attacks points the same way. After 9/11, how much coverage people watched was linked to stress symptoms for three years, and among 744 Israeli teenagers surveyed after the 7 October attack, heavy news-watchers had more symptoms.
Fever after a vaccine traced to gut bacteria
Swipe up for the story ↑Scroll down for the story ↓
A study published in the journal Science on Thursday found that people who ran a fever after a Covid vaccine shared features in their gut bacteria.
Ruth Ley's team at the Max Planck Institute for Biology in Tubingen, Germany, tested stool from more than 170 people before and after a second or third dose.
Those with worse fevers had more flagellin, the protein in the tiny tails bacteria use to swim, and more inflamed guts.
Mice given the fever-linked bacteria reacted strongly, and much less when they could not sense flagellin.
Why it matters
Ley hopes that easing this side effect could one day lead more people to get vaccinated.
Nobody knows yet
Why some people's guts carry more of the bacteria linked to fever after a vaccine.
Vegetarians had less flagellin, but the researchers say the cause needs more study.
1 source
Fever after a vaccine traced to gut bacteria
The full story
Fever after a vaccine traced to gut bacteria
A study published in the journal Science on Thursday found that people who ran a fever after a Covid vaccine shared features in their gut bacteria.
Why it matters. Ley hopes that easing this side effect could one day lead more people to get vaccinated.
England to inspect private ADHD clinics
Swipe up for the story ↑Scroll down for the story ↓
England's care inspector, the Care Quality Commission, said on Friday it will start inspecting private clinics that only diagnose ADHD and autism.
Until now they did not have to register with it.
It follows a government review led by Professor Peter Fonagy, which warned private firms may be tempted to diagnose people who do not qualify.
The NHS Alliance, which represents NHS trusts, confirmed staff are leaving for private clinics.
One NHS trust, Herefordshire and Worcestershire, limited under-18s to the most urgent cases after most of its leavers went private.
Why it matters
About 810,000 children and adults in England are waiting for an assessment, 1,298 of them for two years or more at that one trust.
Why it matters
Thea Stein of the Nuffield Trust, a health research charity, says people who can pay will be seen faster as NHS teams shrink.
Who gains
Private ADHD and autism clinics in England
They hire staff trained in the NHS and are paid by the NHS for assessments under the Right to Choose rules.
Who pays
NHS patients who cannot pay for private care
They wait longer as NHS teams lose staff to private clinics; 1,298 people at one trust have waited two years or more.
1 source
England to inspect private ADHD clinics
The full story
England to inspect private ADHD clinics
England's care inspector, the Care Quality Commission, said on Friday it will start inspecting private clinics that only diagnose ADHD and autism.
Why it matters. About 810,000 children and adults in England are waiting for an assessment, 1,298 of them for two years or more at that one trust.
Census changes would bend US health figures
Swipe up for the story ↑Scroll down for the story ↓
The Trump administration has proposed three changes to the 2030 US census.
It would count only citizens and lawful permanent residents, count people where they lived most between 3 January and 1 April, and stop asking about race, ethnicity and sexual orientation.
The plan was published on 10 September, and public pushback got the comment deadline moved from 13 October to 2 November.
Nancy Krieger, an epidemiologist at Harvard, notes that a death rate is deaths divided by the number of people counted.
Why it matters
If fewer people are counted and the deaths stay the same, US death and illness rates will jump in 2030 without anyone getting sicker, Krieger writes.
Why it matters
Census counts also decide where hospitals and clinics are planned and where federal money goes.
Who gains
Whoever gains House seats from a smaller census count
Nancy Krieger argues the plan's authors expect a party advantage, because seats in the US House of Representatives are shared out by census population.
Who pays
Immigrants, students and people of color in the US
Krieger says the census changes would make their health problems harder to see in official figures.
2 sources
Census changes would bend US health figures
The full story
Census changes would bend US health figures
The Trump administration has proposed three changes to the 2030 US census.
Why it matters. If fewer people are counted and the deaths stay the same, US death and illness rates will jump in 2030 without anyone getting sicker, Krieger writes.
A numbing fluid eases IUD fitting
Swipe up for the story ↑Scroll down for the story ↓
Helena Kopp Kallner, a gynaecologist at the Karolinska Institute in Sweden, told Scientific American about a way to numb the womb before an IUD is fitted.
An IUD is a small T-shaped device placed in the womb that prevents pregnancy for years, and fitting it can be very painful.
Her team runs a numbing drug called mepivacaine through a soft tube 1.3mm wide, with no needle.
Across three trials that let chance decide who got it, with about 600 people, it lowered pain scores and caused no complications.
Why it matters
Ibuprofen taken beforehand is still the most common choice, though many trials show it does not prevent the pain.
Why it matters
The pain was long overlooked because it is brief, and because IUDs used to go mainly to women who had given birth, who feel less of it.
How it works
A trial may hold back a treatment only while doctors truly do not know if it works
How it works
Letting chance decide who gets which treatment is fair only while experts honestly cannot say which is better.
How it works · step 1 of 5
Doctors do not know whether treatment A or B is better
How it works · step 2 of 5
So chance decides who gets which, and both groups are followed
How it works · step 3 of 5
The answer comes in, and the question is closed
How it works · step 4 of 5
After that, giving anyone the weaker option is no longer a test
How it works · step 5 of 5
It is a choice to leave some people less protected
The twist
Letting chance pick who gets a treatment is the fairest test while doctors are unsure. Once they are sure, the coin toss only decides who goes without protection.
The picture
9 of 10
newborns infected with hepatitis B at birth who carry it for life
About 9 in 10 babies who catch hepatitis B at birth keep the virus for life. That is the risk a birth dose is given to stop.
Seen the same day
Nobody knew whether the fluid beat ibuprofen, so chance decided who got it, and after about 600 people Kopp Kallner says doctors can simply use it.
Seen the same day
Nobody yet knows if the diet helps, so comparing veterans who changed diet with a group who did not is still a fair test.
Seen the same day
Nobody can fairly make thousands of people walk slowly for eight years, so researchers watched 64,743 people and can show only a link.
The catch
Doctors can be wrong about what is already known, and the Danish team says it is asking a different question: whether the birth dose has health effects beyond hepatitis B that nobody has measured.
The whole
Newborns cannot agree to a trial, so adults in the US, Denmark and Guinea-Bissau are deciding for them.
The whole
Anyone who has had a vaccine is protected because earlier trials were run fairly and then stopped once the answer was clear.
Who gains
People who get an IUD fitted
Three trials of about 600 people now show a way to numb the fitting with no complications seen.
Good news
In three trials with about 600 people, a numbing drug run through a soft tube 1.3mm wide made fitting an IUD less painful, with no complications seen.
The full story
A numbing fluid eases IUD fitting
Helena Kopp Kallner, a gynaecologist at the Karolinska Institute in Sweden, told Scientific American about a way to numb the womb before an IUD is fitted.
Why it matters. Ibuprofen taken beforehand is still the most common choice, though many trials show it does not prevent the pain.
Muscle and liver cells remember training
Swipe up for the story ↑Scroll down for the story ↓
Exercise scientists, writing in The Conversation and republished by Scientific American on Saturday, described work showing that cells keep a record of past training.
Mice that trained, stopped and trained again grew bigger muscle fibres than mice with no training history.
The liver remembered too: in mice and in people who trained, stopped and restarted, it released more of the enzymes that break down fat so muscle can burn it.
Mice whose parents exercised for three to four weeks had better blood sugar for a year.
Why it matters
It suggests months off for an injury or a new baby do not wipe out all the gains.
Why it matters
The authors say past training cannot replace training now, and most of the evidence so far comes from mice.
Good news
Mice that trained, stopped and then trained again grew bigger muscle fibres than mice training for the first time.
1 source
Muscle and liver cells remember training
The full story
Muscle and liver cells remember training
Exercise scientists, writing in The Conversation and republished by Scientific American on Saturday, described work showing that cells keep a record of past training.
Why it matters. It suggests months off for an injury or a new baby do not wipe out all the gains.
Walking faster matched walking further
Swipe up for the story ↑Scroll down for the story ↓
A study of 64,743 adults in the UK, average age 62, measured their steps and walking pace with wrist trackers for a week, then followed them for about eight years.
During that time 1,697 of them died, 502 from heart and blood vessel disease.
People who took fewer than 5,000 steps a day, but briskly, had a death risk similar to people taking 5,000 to 7,500 slower steps.
The lowest death rates came at 7,500 to 10,000 steps a day.
Why it matters
The authors suggest about 30 minutes a day at 90 to 100 steps a minute as a target, which helps people who are short of time or cannot walk far.
Why it matters
The study watched people rather than assigning them how to walk, so it shows a link, not proof that speed causes the benefit.
How it works
Nobody can fairly make thousands of people walk slowly for eight years, so researchers watched 64,743 people and can show only a link.
The idea, in story 6: A trial may hold back a treatment only while doctors truly do not know if it works →Good news
In a study of 64,743 adults, people who walked fewer than 5,000 steps a day but briskly had a death risk close to people taking up to 7,500 slower steps.
1 source
Walking faster matched walking further
The full story
Walking faster matched walking further
A study of 64,743 adults in the UK, average age 62, measured their steps and walking pace with wrist trackers for a week, then followed them for about eight years.
Why it matters. The authors suggest about 30 minutes a day at 90 to 100 steps a minute as a target, which helps people who are short of time or cannot walk far.
A low-glutamate diet tried on Gulf War veterans
Swipe up for the story ↑Scroll down for the story ↓
Kathleen Holton, a nutrition researcher at American University in Washington, is testing a diet low in glutamate on US veterans with Gulf War Illness.
Up to 300,000 service members sent to the Gulf in the early 1990s later reported fatigue, pain, headaches and memory problems, the US veterans' department says.
Glutamate is a chemical messenger in the brain, and it is also added to food as MSG.
In her 2020 trial of 40 veterans, symptom scores averaged 11.7 after a month, against 18.1 in a group that did not change diet.
Why it matters
Holton says up to 80% of veterans improve, a figure that mixes their own reports with her team's measurements.
Why it matters
In 2022 the US defence department gave her $6.4 million to study more than 100 veterans.
Why it matters
The US food regulator considers MSG safe, partly because a barrier around the brain keeps most glutamate from food out.
How it works
Nobody yet knows if the diet helps, so comparing veterans who changed diet with a group who did not is still a fair test.
The idea, in story 6: A trial may hold back a treatment only while doctors truly do not know if it works →Nobody knows yet
Whether a low-glutamate diet helps more people than a normal healthy diet would.
The first trial had 40 veterans, and Holton's own studies of migraine and brain injury are still running.
1 source
A low-glutamate diet tried on Gulf War veterans
The full story
A low-glutamate diet tried on Gulf War veterans
Kathleen Holton, a nutrition researcher at American University in Washington, is testing a diet low in glutamate on US veterans with Gulf War Illness.
Why it matters. Holton says up to 80% of veterans improve, a figure that mixes their own reports with her team's measurements.
More US counties lose private Medicare drug plans
Swipe up for the story ↑Scroll down for the story ↓
In 2027, 193 US counties will have no private Medicare plan with drug cover open to everyone, up from 123 this year, says KFF, a US health research group.
Medicare is the US government's health insurance for people aged 65 and over, and private Medicare Advantage plans are the alternative to it.
About 638,000 people live in those counties, and there is no such plan anywhere in Alaska.
UnitedHealth Group is leaving 228 counties and entering 9, and Humana is leaving 62 and entering 4.
Why it matters
The average Medicare member can still choose from 28 such plans, so the losses fall on 193 counties in 16 states.
Why it matters
UnitedHealth Group and Humana are the two largest private Medicare insurers.
Who pays
Medicare members in 193 US counties
They will have no private Medicare plan with drug cover next year, up from 123 counties this year.
1 source
More US counties lose private Medicare drug plans
The full story
More US counties lose private Medicare drug plans
In 2027, 193 US counties will have no private Medicare plan with drug cover open to everyone, up from 123 this year, says KFF, a US health research group.
Why it matters. The average Medicare member can still choose from 28 such plans, so the losses fall on 193 counties in 16 states.
A second UK health body drops Teva
Swipe up for the story ↑Scroll down for the story ↓
The Royal College of Pharmacy, the professional body for Britain's pharmacists, has dropped Teva UK as a sponsor of its conference next month.
Teva UK is the British arm of Teva, an Israeli company that mostly makes generic medicines, which are copies of existing drugs.
The college said a review had found Teva activities that did not match its values, without saying which.
Last week the Royal College of Nursing, which represents 500,000 nurses, also cut its ties with Teva.
Why it matters
The college's decision followed an open letter from pro-Palestinian health campaigners, who now want the colleges for GPs, psychiatrists and hospital doctors to do the same.
Why it matters
Teva said healthcare should not become politicised.
Nobody knows yet
Which Teva activities the Royal College of Pharmacy objected to.
The college did not say.
1 source
A second UK health body drops Teva
The full story
A second UK health body drops Teva
The Royal College of Pharmacy, the professional body for Britain's pharmacists, has dropped Teva UK as a sponsor of its conference next month.
Why it matters. The college's decision followed an open letter from pro-Palestinian health campaigners, who now want the colleges for GPs, psychiatrists and hospital doctors to do the same.
Teen podcasts on memory and dyslexia win
Swipe up for the story ↑Scroll down for the story ↓
NPR, the US public radio network, named the winners of its Student Podcast Challenge, chosen from about 1,500 entries.
The high school winner, Amit Biligiri, 16, asked why he forgets last week's lessons but remembers sharing fries with his great-grandfather at age six.
His answer was that emotion gives a memory a better chance of sticking, and sleep clears out much of the rest.
The middle school winner, Cora Walsh, waited almost five years for a diagnosis of dyslexia, a difficulty reading words, and now reads for fun after two years of tutoring.
Why it matters
Research backs part of Amit's answer: emotional moments are often remembered with high confidence, though reviews find the boost does not show up in every study.
Why it matters
Cora hopes her podcast makes dyslexia less frightening for younger students still working out how they learn.
Good news
Cora Walsh waited almost five years for a dyslexia diagnosis. After two years of tutoring she reads the Hunger Games for fun, and her podcast about it won a national prize.
The full story
Teen podcasts on memory and dyslexia win
NPR, the US public radio network, named the winners of its Student Podcast Challenge, chosen from about 1,500 entries.
Why it matters. Research backs part of Amit's answer: emotional moments are often remembered with high confidence, though reviews find the boost does not show up in every study.
Most English adults with high blood pressure do not know
Swipe up for the story ↑Scroll down for the story ↓
An Oxford study, first published before this week and covered by Euronews on 10 October, used clinic readings from about 1.4 million adults in England in the Our Future Health programme.
6 of 10
of every 10 adults with high blood pressure did not know they had it
More than a third had high blood pressure: a reading of 140 over 90 or more, or already taking pills for it.
About 59% of them did not know and were not treated, and half of those on pills were still above that line.
It affected 15% of people aged 18 to 39 and 71% of those aged 80 and over.
Why it matters
England's NHS health check starts at 40, so most young adults with high blood pressure are never routinely tested, says the lead researcher, Wenyu Liu.
Why it matters
The British Heart Foundation says high blood pressure is linked to about half of the UK's heart attacks and strokes.
1 source
Most English adults with high blood pressure do not know
The full story
Most English adults with high blood pressure do not know
An Oxford study, first published before this week and covered by Euronews on 10 October, used clinic readings from about 1.4 million adults in England in the Our Future Health programme.
6 of 10
of every 10 adults with high blood pressure did not know they had it
Why it matters. England's NHS health check starts at 40, so most young adults with high blood pressure are never routinely tested, says the lead researcher, Wenyu Liu.
A blood clue to how the immune system ages
Swipe up for the story ↑Scroll down for the story ↓
Scientists in the US and at King's College London studied about 12.4 million immune cells from the blood of over 2,600 adults aged 20 to over 90.
Older people's immune systems varied more than younger people's.
The team ranked people by the balance between two kinds of white blood cell, one making a protein called granzyme B and one making granzyme K.
Among 50,000 UK Biobank volunteers, those leaning towards granzyme B were more likely to die or develop diabetes, high blood pressure or kidney failure within ten years.
Why it matters
It may help explain why two people born the same year face different risks of disease decades later.
Why it matters
The team is building a simple blood test, but for the 50,000 volunteers the balance was estimated from blood proteins rather than counted, so it is an early clue.
1 source
A blood clue to how the immune system ages
The full story
A blood clue to how the immune system ages
Scientists in the US and at King's College London studied about 12.4 million immune cells from the blood of over 2,600 adults aged 20 to over 90.
Why it matters. It may help explain why two people born the same year face different risks of disease decades later.
Eye-damage lawsuits over weight-loss drugs
Swipe up for the story ↑Scroll down for the story ↓
Dozens of people are suing Novo Nordisk and Eli Lilly, the makers of GLP-1 weight-loss drugs such as Ozempic, MIT Technology Review reports.
They say the drugs damaged the nerves behind their eyes, a rare condition that can bring sudden loss of sight.
Research on whether the drugs cause the condition is mixed so far.
Why it matters
About 11% of Americans now take one of these drugs to lose weight, so even a rare harm could reach many people.
1 source
Eye-damage lawsuits over weight-loss drugs
The full story
Eye-damage lawsuits over weight-loss drugs
Dozens of people are suing Novo Nordisk and Eli Lilly, the makers of GLP-1 weight-loss drugs such as Ozempic, MIT Technology Review reports.
Why it matters. About 11% of Americans now take one of these drugs to lose weight, so even a rare harm could reach many people.
US measles cases pass 4,000
Swipe up for the story ↑Scroll down for the story ↓
The US CDC, the national public health agency, reported 4,080 confirmed measles cases this year as of 8 October, 193 more than a week earlier.
About 1 in 10 patients, 414 people, needed hospital care, against 244 hospital stays in all of 2025.
The CDC counts two measles deaths this year, while Pennsylvania alone has reported five.
Why it matters
Children and teenagers aged 5 to 19 make up 42% of cases, and adults another 40%.
Why it matters
Last month the CDC switched to national death records for its measles death count, a change that has drawn criticism.
The full story
US measles cases pass 4,000
The US CDC, the national public health agency, reported 4,080 confirmed measles cases this year as of 8 October, 193 more than a week earlier.
Why it matters. Children and teenagers aged 5 to 19 make up 42% of cases, and adults another 40%.
A Catholic memorial to people lost to suicide
Swipe up for the story ↑Scroll down for the story ↓
The Catholic archdiocese of Chicago has dedicated a memorial to people who died by suicide and to their families, at the Queen of Heaven cemetery in Hillside, Illinois.
It says this is the first memorial of its kind by any US archdiocese.
Until a church law was revised in 1983, people who died by suicide were refused Catholic burial on consecrated ground.
The memorial honours the Rev Charles Rubey, who in 1979 founded a support programme for families bereaved by suicide.
Why it matters
Catholic teaching now says mental illness can lead people to suicide, and Pope Leo XIV has given monthly prayers to people with suicidal thoughts.
Why it matters
A Vatican meeting on how parishes respond to mental illness is timed for World Mental Health Day, 10 October.
1 source
A Catholic memorial to people lost to suicide
The full story
A Catholic memorial to people lost to suicide
The Catholic archdiocese of Chicago has dedicated a memorial to people who died by suicide and to their families, at the Queen of Heaven cemetery in Hillside, Illinois.
Why it matters. Catholic teaching now says mental illness can lead people to suicide, and Pope Leo XIV has given monthly prayers to people with suicidal thoughts.
Gambling-addiction charity chief quits over Kalshi money
Swipe up for the story ↑Scroll down for the story ↓
Heather Maurer, head of the National Council on Problem Gambling, the largest US charity against gambling addiction, resigned in late September, as Barron's first reported and Fortune repeated on 9 October.
She had accepted $2 million from Kalshi, a prediction market where people bet on events, without asking the board first.
Directors asked whether Kalshi would pay for safety measures or promote addiction helplines, and she said it would not.
Gambling councils in Washington and Nevada, and gaming regulators in Ohio and Michigan, cut ties with the charity over the gift.
Why it matters
Prediction markets let anyone aged 18 or over bet on almost anything, and advocates say that easy access raises the risk of addiction.
Why it matters
Kalshi says its business is not gambling, so the charity created a separate donor category for it.
1 source
Gambling-addiction charity chief quits over Kalshi money
The full story
Gambling-addiction charity chief quits over Kalshi money
Heather Maurer, head of the National Council on Problem Gambling, the largest US charity against gambling addiction, resigned in late September, as Barron's first reported and Fortune repeated on 9 October.
Why it matters. Prediction markets let anyone aged 18 or over bet on almost anything, and advocates say that easy access raises the risk of addiction.
Australian PMOS group asks for subsidised weight-loss drugs
Swipe up for the story ↑Scroll down for the story ↓
An Australian patient group wants GLP-1 weight-loss drugs paid for by Australia's government medicine subsidy scheme for women with PMOS.
PMOS, the new name for polycystic ovary syndrome, affects about one in eight women and raises the risk of type 2 diabetes, heart disease and cancer of the womb lining.
Doctors already prescribe the drugs for it outside their approved use, at a cost of several hundred dollars a month.
Australia's medicines advisory committee meets next month to consider subsidising Wegovy for obesity.
Why it matters
Magdalena Simonis of the Royal Australasian College of Physicians says subsidies for PMOS may never come, because women's conditions are traditionally left out.
Why it matters
QENDO, another patient group, says more research is needed on long-term safety for PMOS.
1 source
Australian PMOS group asks for subsidised weight-loss drugs
The full story
Australian PMOS group asks for subsidised weight-loss drugs
An Australian patient group wants GLP-1 weight-loss drugs paid for by Australia's government medicine subsidy scheme for women with PMOS.
Why it matters. Magdalena Simonis of the Royal Australasian College of Physicians says subsidies for PMOS may never come, because women's conditions are traditionally left out.
That's the whole Mind & body day.
19 stories, 37 sources.